{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:27:11Z","timestamp":1759692431662,"version":"3.37.3"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.neuropharm.2012.05.020","type":"journal-article","created":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T21:08:39Z","timestamp":1338239319000},"page":"675-684","source":"Crossref","is-referenced-by-count":22,"title":["Noradrenergic antidepressants increase cortical dopamine: Potential use in augmentation strategies"],"prefix":"10.1016","volume":"63","author":[{"given":"Merc\u00e8","family":"Masana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anal\u00eda","family":"Bortolozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2012.05.020_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2005.01202.x","article-title":"Cost of disorders of the brain in Europe","volume":"12","author":"Andlin-Sobocki","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch.Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib5","first-page":"25","article-title":"Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain","volume":"20","author":"Beck","year":"1995","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/syn.890150310","article-title":"Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei","volume":"15","author":"Bel","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1098-2396(199711)27:3<230::AID-SYN8>3.0.CO;2-E","article-title":"Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens","volume":"27","author":"Berridge","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study","volume":"167","author":"Blier","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.npp.1300061","article-title":"Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors","volume":"28","author":"Bortolozzi","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in\u00a0vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.326.7403.1343","article-title":"Electroconvulsive therapy","volume":"326","author":"Carney","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A\u00a0double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2009.06.018","article-title":"Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse","volume":"616","author":"Castagne","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.05.020_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0014-2999(93)90034-F","article-title":"Effect of fluoxetine on the spontaneous electrical activity of fronto-cortical neurons","volume":"250","author":"Ceci","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib16","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1111\/j.1460-9568.2008.06230.x","volume":"27","author":"Chandramohan","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.16.9.1365","article-title":"Triple uptake inhibitors: therapeutic potential in depression and beyond","volume":"16","author":"Chen","year":"2007","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(99)00492-6","article-title":"Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat","volume":"379","author":"Connor","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the\u00a0mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-8993(98)00672-6","article-title":"Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat","volume":"806","author":"Delfs","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157015906776359559","article-title":"On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?","volume":"4","author":"Devoto","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.mp.4000904","article-title":"Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex","volume":"6","author":"Devoto","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2004.02866.x","article-title":"Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex","volume":"92","author":"Devoto","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of neurotrophic factors in the etiology and treatment of mood disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0306-4522(98)00258-9","article-title":"Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test","volume":"88","author":"Espejo","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","article-title":"Nucleus locus ceruleus: new evidence of anatomical and physiological specificity","volume":"63","author":"Foote","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib31","first-page":"3","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacolgy (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0006-3223(99)00130-4","article-title":"The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia","volume":"46","author":"Goldman-Rakic","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/026988119901300321","article-title":"Do antidepressants have any potential to cause addiction?","volume":"13","author":"Haddad","year":"1999","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2004.05.026","article-title":"Role of presynaptic alpha2-adrenoceptors in\u00a0antidepressant action: recent findings from microdialysis studies","volume":"28","author":"Invernizzi","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib35","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","article-title":"Profound neuronal plasticity in response to inactivation of the dopamine transporter","volume":"95","author":"Jones","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib36","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.\u00a0S.\u00a0A"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(01)00863-9","article-title":"The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis","volume":"418","author":"Kawahara","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnins.2010.00192","article-title":"A\u00a0new strategy for antidepressant prescription","volume":"4","author":"Lavergne","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhr220","article-title":"5\u2013HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","author":"Llado-Pelfort","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.WNF.0000228211.19818.14","article-title":"Reboxetine addition in patients with mirtazapine-resistant depression: a case series","volume":"29","author":"Lopez-Munoz","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S1461145710000908","article-title":"Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia","volume":"14","author":"Masana","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1471-4159.1998.71020790.x","article-title":"Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in\u00a0vivo modulation of cortical noradrenaline release by the antidepressant desipramine","volume":"71","author":"Mateo","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib46","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.bjp.0704196","article-title":"Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study","volume":"133","author":"Mateo","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(02)02542-8","article-title":"Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat","volume":"936","author":"Mazei","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"Millan","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00213-004-2072-7","article-title":"Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect","volume":"177","author":"Miyata","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib52","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.euroneuro.2010.07.008","article-title":"In\u00a0vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by alpha(2)-adrenoceptor antagonism","volume":"20","author":"Ortega","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00213-002-1269-x","article-title":"Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in\u00a0a rat model of antidepressant action","volume":"165","author":"Page","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/da.20181","article-title":"The combination of duloxetine and bupropion for treatment-resistant major depressive disorder","volume":"23","author":"Papakostas","year":"2006","journal-title":"Depress. Anxiety"},{"year":"1998","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.neuropharm.2012.05.020_bib57"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib58","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0140-6736(96)08007-5","article-title":"Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment","volume":"349","author":"Perez","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.56.4.375","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius","volume":"56","author":"Perez","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib60","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib61","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4088\/JCP.09m05827blu","article-title":"Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression","volume":"72","author":"Portella","year":"2011","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1471-4159.1994.63010195.x","article-title":"Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats","volume":"63","author":"Pozzi","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib63","first-page":"1","article-title":"Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression","author":"Puigdemont","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"Reneric","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0893-133X(00)00214-1","article-title":"Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA\/5-HT reuptake inhibition in the rat forced swimming test","volume":"24","author":"Reneric","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0924-977X(02)00007-X","article-title":"In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed","volume":"12","author":"Reneric","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2012.05.020_bib67","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/sj.npp.1300514","article-title":"Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise","volume":"29","author":"Russo-Neustadt","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib68","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/sj.bjp.0702926","article-title":"Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain","volume":"128","author":"Sacchetti","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"4857","key":"10.1016\/j.neuropharm.2012.05.020_bib69","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.3131879","article-title":"Expression of c-fos protein in brain: metabolic mapping at the cellular level","volume":"240","author":"Sagar","year":"1988","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neuropharm.2012.05.020_bib70","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0028-3908(02)00329-5","article-title":"Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment","volume":"43","author":"Salchner","year":"2002","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2012.05.020_bib71","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","article-title":"Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine","volume":"69","author":"Santana","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2010.04.012","article-title":"Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice","volume":"59","author":"Scorza","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0306-4522(90)90079-J","article-title":"Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections","volume":"35","author":"Seguela","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib74","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/sj.npp.1300717","article-title":"Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds","volume":"30","author":"Slattery","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"7367","key":"10.1016\/j.neuropharm.2012.05.020_bib75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/478015a","article-title":"Trillion-dollar brain drain","volume":"478","author":"Smith","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib76","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1073\/pnas.091039298","article-title":"Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference","volume":"98","author":"Sora","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib77","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1523\/JNEUROSCI.3100-11.2011","article-title":"Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory","volume":"31","author":"Stone","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib78","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Svenningsson","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib79","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(98)00147-X","article-title":"Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type\u00a01 receptor in rat brain","volume":"87","author":"Torres","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib80","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.05.020_bib81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hipo.10037","article-title":"The entorhinal cortex of the mouse: organization of the projection to the hippocampal formation","volume":"13","author":"van Groen","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib82","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0269881108097714","article-title":"Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review","volume":"24","author":"Whale","year":"2010","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.020_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-6147(92)90063-C","article-title":"Neurobiology of cocaine abuse","volume":"13","author":"Woolverton","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2012.05.020_bib84","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.neuropharm.2012.01.024","article-title":"A\u00a0combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain","volume":"62","author":"Yamauchi","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.020_bib85","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1523\/JNEUROSCI.2309-09.2010","article-title":"Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment","volume":"30","author":"Yanpallewar","year":"2010","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:53:26Z","timestamp":1617620006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0028390812002183"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}